Mangoceuticals, Inc. (MGRX) Stock

NASDAQ: MGRXDevelops nutraceuticals and dietary supplements, focusing on natural health products derived from mangoes.

Mangoceuticals stock price chart

MGRX interactive chart →

MGRX stock quote & key statistics

Mangoceuticals earnings per share

Income →

Earnings per share

Mangoceuticals revenue & net income

Income →

RevenueNet income

Mangoceuticals annual financials

Income statement →

Mangoceuticals, Inc. revenue, net income and EPS by fiscal year
Fiscal year	Revenue	Net income	EPS
FY2025	$456,021	-$20.6M	-$2.71
FY2024	$615,873	-$8.7M	-$5.00
FY2023	$731,493	-$9.2M	-$5.77
FY2022	$8,939	-$2.0M	-$0.08

Fiscal year ending December 31. Source: company filings via EODHD.

About Mangoceuticals, Inc.

Mangoceuticals, Inc. specializes in developing, marketing, and distributing a range of men's wellness products and services across the United States, utilizing a telemedicine platform for convenient access and customer support.

Under the Mango brand, the company offers products tailored for erectile dysfunction (ED), while its Grow brand focuses on solutions for hair loss. These specialized products are marketed and sold directly to consumers through Mangoceuticals' dedicated online platform, MangoRx.com.

In addition to its branded offerings, Mangoceuticals, Inc. has forged a strategic marketing agreement with Marius Pharmaceuticals, LLC, enabling the company to promote and distribute KYZATREX, an oral testosterone replacement therapy product, under the PRIME program. Founded in 2021 and headquartered in Dallas, Texas, Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc., reinforcing its commitment to enhancing men's health and wellness through innovative telemedicine solutions.

Mangoceuticals stock FAQ

What is the Mangoceuticals stock ticker symbol?

Mangoceuticals, Inc. trades on the NASDAQ under the ticker symbol MGRX.

What sector and industry is Mangoceuticals in?

Mangoceuticals, Inc. is classified in the Healthcare sector, Health Information Services industry.

How many employees does Mangoceuticals have?

Mangoceuticals, Inc. has about 3 full-time employees.

What were Mangoceuticals's revenue and earnings last fiscal year?

Mangoceuticals reported revenue of $456,021 and net income of -$20.6M in fiscal 2025, with earnings per share of -$2.71. Revenue declined 26.0% from the prior year.

When did Mangoceuticals go public?

Mangoceuticals stock began trading on March 21, 2023.